Medicare utilization — TAYLOR BRIANNE WARMOTH (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,150 | 15 | $0 | $134,601 |
| J0897 | Injection, denosumab, 1 mg | 3,975 | 39 | $0 | $72,718 |
| 36415 | Insertion of needle into vein for collection of blood sample | 463 | 240 | $0 | $3,176 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 417 | 38 | $0 | $323 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 390 | 186 | $0 | $2,922 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·